郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics, and in vivo potency.

期刊:Journal of medicinal chemistry发表年份:2006作者:Alan D Borthwick; Dave E Davies; Anne M Exall; Richard J D Hatley; Jennifer A Hughes; Wendy R Irving; David G Livermore; Steve L Sollis; Fabrizio Nerozzi; Klara L Valko; Michael J Allen; Marion Perren; Shalia S Shabbir; Patrick M Woollard; Mark A Pri

药效评价Highly potent and selective phenylmorphan-based inverse agonists of the opioid delta receptor.

期刊:Journal of medicinal chemistry发表年份:2006作者:James B Thomas; Li Zhang; Hernan A Navarro; F Ivy Carroll

药效评价Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor.

期刊:The Journal of pharmacology and experimental therapeutics发表年份:2006作者:Rosemarie Macion-Dazard; Nicholas Callahan; Zhen Xu; Nan Wu; Marc Thibonnier; Menachem Shoham

药效评价A novel class of positive allosteric modulators of metabotropic glutamate receptor subtype 1 interact with a site distinct from that of negative allosteric modulators.

期刊:Molecular pharmacology发表年份:2006作者:Kamondanai Hemstapat; Tomas de Paulis; Yelin Chen; Ashley E Brady; Vandana K Grover; David Alagille; Gilles D Tamagnan; P Jeffrey Conn